Drugdiscovery >> Pharmaceutical Companies >> News
4246
Views
The price of AstraZeneca 's stock increased after Pfizer's offer - drugdiscovery.com
The price of AstraZeneca 's stock increased after Pfizer's offer - drugdiscovery.com


The price of AstraZeneca stocks runned up after Pfizer announced that it is willing to buy o buy the company for around $100 billion. Lately, AstraZeneca turned down another similar offer.
Read More >>


Tags: Stock, pharmaceutival business, pharmaceutical companies, AstraZeneca,Pfizer, pharmaceutical stock exchange, pharma stocks, astrazeneca sold - April 29, 2014
Related Articles
3506
Views
Best stock perfoming pharmaceutical companies of 2013 Best stock perfoming pharmaceutical companies of 2013
A list and a brief explanation for best performing phamraceutical companies 2013. Biotech firms, researchers and tool providers are also listed. Read More >>

Tags: pharma, stock exchange, performance, pharmaceutical companies

5146
Views
What is happening with AstraZeneca. What is happening with AstraZeneca.
Pfizer announced to buy AstraZeneca many times. But what is in the backround of this diecision and what is happening with the two companies? Read More >>

Tags: Astra Zeneca, Pfizer, pharmaceutical companies, astraZeneca business.

3031
Views
AstraZeneca buys anti-diabetes giant AstraZeneca buys anti-diabetes giant
AstraZeneca PLC will buy out Bristol-Myers Squibb. This opens a new market for the anglo-swedish company to sell drugs. According to the company this helps to make diabetes drugs free and good Read More >>

Tags: AstraZeneca,Birstol Myers Squibb, diabeters

4190
Views
AstraZeneca links with privately held company to research cancer AstraZeneca links with privately held company to research cancer
AstraZeneca has announced that its biologic development arm is going to co-operate with Immunocore Limited. This is a privately held company and works on T-cell related researches. Read More >>

Tags: T-cell, AstraZeneca, Immunocore, co-operation

1573
Views
AstraZeneca CFO to join BG AstraZeneca CFO to join BG
Simon Lowth, chief financial officer at AstraZeneca, is leaving the pharmaceutical company to take on the same role at oil and gas group BG. Read More >>

Tags: AstraZeneca,Simon Lowth

5105
Views
AstraZeneca: New Partnership in Combat Kidney Disease AstraZeneca: New Partnership in Combat Kidney Disease
Evotec AG and AstraZeneca step into fellowship to fight kidney disease. The two giants are working on finding new possibilities and components, which might modify disease and help the quick recovery o Read More >>

Tags: contrect, Evotec AG, AstraZeneca, kidney

4239
Views
AstraZeneca and Pfizer merger: Do cancer patients loose? AstraZeneca and Pfizer merger: Do cancer patients loose?
Even the most-sold drug of Pfizer was an aquisition. therefore, expert predict that the company can only survive if it merges with others. Read More >>

Tags: pfizer, astrazeneca, pfizer merge, astra zeneca aquisition

4812
Views
AstraZeneca pleased with quarter despite profits fall AstraZeneca pleased with quarter despite profits fall
Patent expiries continue to hurt sales and earnings Read More >>

Tags: AstraZeneca, profits

846
Views
Full consumer unit controll is going to be bought by GSK in Indonesia Full consumer unit controll is going to be bought by GSK in Indonesia
Indonesia is one of the rapidly growing markets that drugmakers are trying to tap to boost sales, and GlaxoSmithKline is going to own the full control of consumer unit. Read More >>

Tags: GSK, indonesia, stock, stocck exchange

4791
Views
AstraZeneca - Hadasit alliance AstraZeneca - Hadasit alliance
AstraZeneca and Hadasit have made a collaboration agreement on novel drug discovery across a broad range of diseases , with a primary focus on cancer, respiratory diseases and diabetes. Read More >>

Tags: AstraZeneca, Hadasit, alliance, collaboration

MOST VIEWED
HOME | ABOUT | PRIVACY POLICY | TERMS & CONDITIONS | ADVERTISE | CONTACT
All rights reserved drugdiscovery.com 2013